Brooke Golden
Medical · Alabaster, ALNPI 1457094161
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations.
Across 67 payments — averaging $40.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$398
- Lilly USA, LLC$350
- Sanofi$306
- AbbVie$292
- Dermavant Sciences, Inc.$291
- Novartis$277
- plus $775 from 12 others
What the payments were for
- Food & beverage$2,60997%
- Education$803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 11 | $398 |
| Lilly USA, LLC | 3 | $350 |
| Sanofi | 3 | $306 |
| AbbVie | 6 | $292 |
| Dermavant Sciences, Inc. | 13 | $291 |
| Novartis | 6 | $277 |
| Organon | 2 | $184 |
| Pfizer | 4 | $147 |
| Galderma Laboratories, L.p. | 3 | $100 |
| Organogenesis Inc. | 3 | $80 |
| Mayne Pharma Commercial LLC | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| LEO Pharma Inc. | 2 | $38 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $33 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Kerecis Limited | 1 | $21 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Bioventus LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,689 in reported general payments places this provider in the 75th percentile of 175 medical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 335 | $8,362 |
| Clobetasol Propionate | 82 | $4,310 |
| Triamcinolone Acetonide | 236 | $2,950 |
| Fluorouracil | 31 | $2,659 |
| Ciclopirox | 65 | $1,870 |
| Clindamycin Phosphate | 41 | $1,820 |
| Ammonium Lactate | 60 | $1,658 |
| Fluocinonide | 35 | $1,545 |
| Doxycycline Hyclate | 72 | $1,407 |
| Metronidazole | 12 | $962 |
| Hydrocortisone | 27 | $436 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 17 | $388 |
| Mupirocin | 37 | $313 |
| Cephalexin | 32 | $267 |
| Fluconazole | 11 | $225 |
Paid to pharmacies, not to this prescriber.
Other medical in Alabaster
- Katherine RoseAlabaster$3K
- Lindsey MangumFlorence$44K
- Jaime DunnBirmingham$16K
- Stacy RichersonMobile$12K
- Susannah CashAuburn$11K
- Deana PorterAuburn$9K
- Rachel ThompsonFairhope$9K
- Shelley WinzelerHomewood$8K
- Reiga EvansHuntsville$8K
- Lillian ShafferCullman$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.